Search Results - "González Barón, Manuel"

Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis by Isidoro, Antonio, Casado, Enrique, Redondo, Andrés, Acebo, Paloma, Espinosa, Enrique, Alonso, Andrés M., Cejas, Paloma, Hardisson, David, Fresno Vara, Juan A., Belda-Iniesta, Cristobal, González-Barón, Manuel, Cuezva, José M.

“…The aim of this study was to investigate selected proteomic markers of the metabolic phenotype of breast carcinomas as prognostic markers of cancer…”
Get full text

Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer by Espinosa, Enrique, Sánchez-Navarro, Iker, Gámez-Pozo, Angelo, Marin, Alvaro Pinto, Hardisson, David, Madero, Rosario, Redondo, Andrés, Zamora, Pilar, San José Valiente, Belén, Mendiola, Marta, González Barón, Manuel, Fresno Vara, Juan Angel

“…Gene profiling may improve prognostic accuracy in patients with early breast cancer, but this technology is not widely available. We used commercial assays for…”
Get full text

Long term responses with cetuximab therapy in glioblastoma multiforme by Rosario Perona, Javier de Castro Carpeño, Enrique Casado Saenz, Manuel Gutiérrez, Cristóbal Belda-Iniesta, Manuel González-Barón

“…Glioblastoma multiforme (GBM) is responsible for most of the deaths associated with primary brain tumors. Standard treatment includes maximal surgical…”
Get full text

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer by Sánchez-Navarro, Iker, Gámez-Pozo, Angelo, Pinto, Alvaro, Hardisson, David, Madero, Rosario, López, Rocío, San José, Belén, Zamora, Pilar, Redondo, Andrés, Feliu, Jaime, Cejas, Paloma, González Barón, Manuel, Angel Fresno Vara, Juan, Espinosa, Enrique

“…Gene expression profiling may improve prognostic accuracy in patients with early breast cancer. Our objective was to demonstrate that it is possible to develop…”
Get full text

mTOR pathway inhibition in renal cell carcinoma by Pinto Marín, Alvaro, M.D., Ph.D, Redondo Sánchez, Andrés, M.D., Ph.D, Espinosa Arranz, Enrique, M.D., Ph.D, Zamora Auñón, Pilar, M.D., Ph.D, Castelo Fernández, Beatriz, M.D., Ph.D, González Barón, Manuel, M.D., Ph.D

“…Abstract Renal cell carcinoma therapy has changed in a very significant way in the last few years. Up to 5 new agents have been developed, improving the…”
Get full text

EGFR and colon cancer: a clinical view by de Castro-Carpeño, Javier, Belda-Iniesta, Cristóbal, Sáenz, Enrique Casado, Agudo, Elena Hernández, Batlle, Jaime Feliu, Barón, Manuel González

“…Signalling pathways that emerge from EGFR activation are critical in colon cancer (CC) biology. Its targeting with specific drugs has opened a new window in…”
Get full text

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis by Cejas, Paloma, López-Gómez, Miriam, Aguayo, Cristina, Madero, Rosario, de Castro Carpeño, Javier, Belda-Iniesta, Cristóbal, Barriuso, Jorge, Moreno García, Víctor, Larrauri, Javier, López, Rocío, Casado, Enrique, Gonzalez-Barón, Manuel, Feliu, Jaime

“…KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients…”
Get full text

Molecular biology of pancreatic cancer by Belda-Iniesta, Cristóbal, Ibáñez de Cáceres, Inmaculada, Barriuso, Jorge, de Castro Carpeño, Javier, González Barón, Manuel, Feliú, Jaime

“…Pancreatic cancer is a leading cause of cancer death. This devastating disease has the horrible honour of close to equal incidence and mortality rates. Late…”
Get full text

Retroperitoneal Castleman’s disease with colon cancer. A rare association by Gómez-Raposo, César, Nistal, Manuel, De Castro Carpeño, Javier, Sosa Rotundo, Grevelyn, Belda-Iniesta, Cristóbal, Casado, Enrique, González Barón, Manuel

“…Castleman’s disease (CD) is a rare disorder of uncertain aetiology characterised by massive proliferation of lymphoid tissue usually localised as mediastinal…”
Get full text

Idiopathic and recurrent thromboembolic phenomena in cancer patients by López-Gómez, Miriam, Gómez-Raposo, César, Sereno Moyano, María, Casado-Sáenz, Enrique, Feliú Batlle, Jaime, Ortega Ruipérez, Carolina, González Barón, Manuel

“…Background Venous thromboembolism (VTE) is one of the most common complications in cancer patients. It is not only associated with both reduced survival and a…”
Get full text

Nutrition and pharyngeal cancer: Results from a case-control study in Spain by Uzcudun, Ana Escribano, Retolaza, Iñaki Rabanal, Fernández, Pilar Bravo, Sánchez Hernández, José Javier, Grande, Antonio García, García, Alfredo García, Olivar, Lara Miralles, de Diego Sastre, Ignacio, Barón, Manuel González, Bouzas, José Gavilán

“…Background Oropharyngeal and hypopharyngeal cancer is increasing all over the world, frequently affecting more and more women and younger individuals and not…”
Get full text

Renal tolerance to cisplatin in patients 70 years and older by CUBILLO, Antonio, CORNIDE, Maria, LOPEZ, Jose Luis, MOLINA, Raquel, FELIU, Jaime, ESPINOSA, Enrique, ZAMORA, Pilar, DE CASTRO, Javier, ORDONEZ, Amalio, GONZALEZ BARON, Manuel

“…The purpose of this study was to evaluate cisplatin nephrotoxicity in patients 70 years and older and to identify factors influencing nephrotoxicity…”
Get full text

Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia by Gómez Raposo, César, Pinto Marín, Alvaro, González Barón, Manuel

“…The hematopoietic growth factors (HGFs) are a family of glycoproteins which plays a major role in the proliferation, differentiation, and survival of primitive…”
Get full text

Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment by PINTO MARIN, Alvaro, REDONDO SANCHEZ, Andrés, ESPINOSA ARRANZ, Enrique, ZAMORA AUNON, Pillar, GONZALEZ BARON, Manuel

“…Complaints of loss of memory and lack of concentration have been reported by long-term survivors of breast cancer. This mild cognitive impairment (MCI), also…”
Get full text

Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach by Belda-Iniesta, Cristóbal, de Castro Carpeño, Javier, Sereno, María, González-Barón, Manuel, Perona, Rosario

“…High-grade gliomas are the most common primary malignant brain tumours. Surgery, radiotherapy and chemotherapy are the cornerstone of actual treatment. In…”
Get full text

Employment in a cohort of cancer patients in Spain. A predictive model of working outcomes by Molina, Raquel, Feliu, Jaime, Villalba, Alejandro, San José, Belén, Jiménez, Ana María, Espinosa, Enrique, Álvarez-Mon, Melchor, González-Barón, Manuel

“…Introduction Cancer patients can have problems remaining in employment but the importance of this issue has until now received little attention in Spain…”
Get full text

Molecular biology of malignant gliomas by Belda-Iniesta, Cristóbal, de Castro Carpeño, Javier, Casado Sáenz, Enrique, Cejas Guerrero, Paloma, Perona, Rosario, González Barón, Manuel

“…Gliomas are the most common primary brain tumours. In keeping with the degree of aggressiveness, gliomas are divided into four grades, with different…”
Get full text

Oncopaz cooperative group by González Barón, Manuel, Espinosa, Enrique

Get full text

Can This Patient Be Discharged Home? Factors Associated With At-Home Death Among Patients With Cancer by Alonso-Babarro, Alberto, Bruera, Eduardo, Varela-Cerdeira, María, Boya-Cristia, María Jesús, Madero, Rosario, Torres-Vigil, Isabel, De Castro, Javier, González-Barón, Manuel

“…The purpose of this study was to identify factors associated with at-home death among patients with advanced cancer and create a decision-making model for…”
Get full text

Clinical Role of Sm-153 EDTMP in the Treatment of Painful Bone Metastatic Disease by Coronado, Mónica, Redondo, Andrés, Coya, Juan, Espinosa, Enrique, Couto, Rosa M, Zamora, Pilar, Marin, Ma Dolores, Castelo, Beatriz, Lillo, Ma Eugenia, Frutos, Laura, Barón, Manuel González, Curto, Luis M. Martín

“…PURPOSE:Sm-153 EDTMP is an effective treatment of painful bone metastases from different neoplasms. However, there are few studies describing clinical…”
Get full text